Search - tctmd.com

Displaying 501 - 520 of 532

Sort: Relevancy | Date

Presentation TCT 2012

Lessons from the PARTNER Trials

Presenter: Stuart Pocock

October 24, 2012

Presentation TCT 2012

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial

Presenter: Mathew Williams

October 23, 2012

Presentation TCT 2012

Update from the Randomized PARTNER 2A Trial

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

New Data from the PARTNER Continued Access (Non-randomized): Transfemoral Outcomes After TAVR

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Presenter: Todd Dewey

October 22, 2012

Presentation TCT 2012

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Presenter: Neil Weissman

October 22, 2012

News Industry News

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

October 19, 2012

News Daily News

Tras la transfusión TAVR Atado a una Mayor Mortalidad

August 16, 2012

News Daily News

Post-TAVR Transfusion Tied to Increased Mortality

August 16, 2012

News Daily News

Punto de Vista de JAMA: La Promesa de la TAVR Debe Sopesarse teniendo en cuenta los Riesgos y las Limitaciones

Yael L. Maxwell

August 09, 2012

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Daily News

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

August 02, 2012

News Daily News

Según un Análisis del BMJ el uso de la TAVR en Europa Sobrepasa a las Evidencias

August 02, 2012

News Daily News

Un Registro Revela una Mejor Supervivencia para las Mujeres que para los Hombres con la TAVR

Caitlin E. Cox

July 19, 2012

News Daily News

Registry Shows Better Survival for Women vs. Men After TAVR

Caitlin E. Cox

July 19, 2012

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Daily News

PARTNER A: La TAVR Transfemoral Mejora la CDV Precoz frente a la Cirugía

July 19, 2012

News Daily News

Tras Implantar la Válvula Sapien No suele hacerse Necesario un Marcapasos Permanente

L.A. McKeown

July 18, 2012

Advertisement

Lessons from the PARTNER Trials

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial

Update from the Randomized PARTNER 2A Trial

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

New Data from the PARTNER Continued Access (Non-randomized): Transfemoral Outcomes After TAVR

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

Tras la transfusión TAVR Atado a una Mayor Mortalidad

Post-TAVR Transfusion Tied to Increased Mortality

Punto de Vista de JAMA: La Promesa de la TAVR Debe Sopesarse teniendo en cuenta los Riesgos y las Limitaciones

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

Según un Análisis del BMJ el uso de la TAVR en Europa Sobrepasa a las Evidencias

Un Registro Revela una Mejor Supervivencia para las Mujeres que para los Hombres con la TAVR

Registry Shows Better Survival for Women vs. Men After TAVR

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

PARTNER A: La TAVR Transfemoral Mejora la CDV Precoz frente a la Cirugía

Tras Implantar la Válvula Sapien No suele hacerse Necesario un Marcapasos Permanente

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content